Here are some of the latest top stories on Healio.com/OSN:
MicroPulse not just for end-stage glaucoma patients
Traditional diode transscleral cyclophotocoagulation has been deeply ingrained as a procedure intended for patients with severe end-stage glaucoma and poor vision. Read more.
FDA tentatively approves Alembic’s bimatoprost solution
The FDA has issued tentative approval for Alembic Pharmaceuticals’ abbreviated new drug application for bimatoprost ophthalmic solution 0.03%. Read more.
Early study results positive for AU-011 in patients with choroidal melanoma<
Uncategorized